Two pharmaceutical giants now offer oral GLP-1 weight loss pills. Eli Lilly’s Foundayo (orforglipron) and Novo Nordisk’s oral Wegovy represent different approaches to the same goal: effective weight loss without injections.
Weight Loss Results
Foundayo (Orforglipron): 12.4% average weight loss over 36 weeks Wegovy Pill (Semaglutide): 16.6% average weight loss over 68 weeks
Wegovy pill shows superior weight loss, but the trials used different durations. Head-to-head studies are ongoing.
How They Work Differently
Foundayo Mechanism:
- Dual GLP-1 and GIP receptor agonist (like Zepbound)
- Non-peptide small molecule structure
- Once-daily dosing
- Works on multiple hormone pathways
Wegovy Pill Mechanism:
- Pure GLP-1 receptor agonist
- Peptide-based molecule (same as injection)
- Once-daily dosing
- Focused GLP-1 pathway targeting
Pricing and Availability
Foundayo:
- Launch price: $199/month (introductory)
- Regular pricing expected around $1,200-1,400/month
- Limited availability through Q2 2026
- Eli Lilly’s savings program covers eligible patients
Wegovy Pill:
- Introductory price: $149/month (first 6 months)
- Regular price: $1,349/month
- Wider availability as of Q1 2026
- Novo Nordisk savings card available
Side Effects Comparison
Both medications share common GLP-1 side effects, but with notable differences:
Common to Both:
- Nausea (most frequent)
- Vomiting
- Diarrhea
- Decreased appetite
Foundayo-Specific:
- Lower reported nausea rates (35% vs 44%)
- More frequent headaches
- Potential for drug interactions due to novel structure
Wegovy Pill-Specific:
- Higher initial nausea rates
- More established side effect profile
- Requires empty stomach administration
Who Benefits Most from Each
Choose Foundayo If:
- You experience severe nausea on other GLP-1s
- You want potentially faster initial results
- You prefer supporting Eli Lilly’s innovation
- You qualify for their patient assistance program
Choose Wegovy Pill If:
- You want proven long-term weight loss data
- You prefer established medication with known effects
- Your insurance covers Novo Nordisk products
- You want the most weight loss potential
Insurance and Access
Foundayo: Limited insurance coverage initially. Most plans require prior authorization and step therapy through other GLP-1 options first.
Wegovy Pill: Growing insurance acceptance. Many plans cover with prior authorization, leveraging the established injectable Wegovy coverage.
Clinical Trial Quality
Wegovy pill benefits from longer, larger clinical trials with more diverse populations. Foundayo’s trials, while promising, involved smaller groups over shorter periods.
The Bottom Line
Wegovy pill currently offers superior weight loss results and broader availability. Foundayo provides an alternative for patients who don’t tolerate traditional GLP-1s well, but needs more long-term data.
Both represent significant advances in oral weight loss medication. Your choice depends on individual tolerance, insurance coverage, and weight loss goals.
Medical disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any treatment.
Health Disclaimer: BestMedsHub is not a healthcare provider, telehealth service, pharmacy, or medical organization. We do not prescribe medication, diagnose conditions, render medical opinions, or facilitate clinical consultations. All content is for general informational and comparison purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified physician, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any treatment, medication, supplement, or health program. Never disregard professional medical advice or delay seeking it because of anything you have read on this site. If you think you may have a medical emergency, call your local emergency number immediately.
FDA & Prescription Medication Disclaimer: Prescription medications referenced on this page are available only through a licensed healthcare provider after a clinical evaluation, and may not be appropriate or safe for everyone. Any statements regarding dietary supplements, wellness products, or off-label uses have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary and are not guaranteed. Always read the medication guide and consult your prescriber and pharmacist about side effects, contraindications, and drug interactions.
